OTCMKTS:SHPMF

Shanghai Pharmaceuticals (SHPMF) Stock Forecast, Price & News

$1.96

-0.08 (-3.93%)

(As of 05/11/2023)

Compare

Today's Range: $1.96
▼
$1.96
50-Day Range: $1.86
▼
$2.04
52-Week Range: $1.28
▼
$2.08

Volume: 1,400 shs
Average Volume: 3,258 shs
Market Capitalization: N/A

P/E Ratio: 2.10
Dividend Yield: 13.44%
Price Target: N/A

Profile Analyst Ratings Chart Competitors Financials Headlines Short Interest

About Shanghai Pharmaceuticals

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Receive SHPMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shanghai Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SHPMF Stock News Headlines

April 18, 2023 | americanbankingnews.com

Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMF) Sees Significant Growth in Short Interest

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SHPMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shanghai Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical Distribution
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:SHPMF
CUSIP: N/A
CIK: 1570300
Web: www.sphchina.com
Phone: N/A
Fax: N/A
Employees: 48,136
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 2.10
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Man Cho (Age 62)
Pres & Exec. Director
Comp: $849.09k

Mr. Bo Shen (Age 50)
CFO, VP, Head of the Accounting Department & Exec. Director
Comp: $786.55k

Mr. Yongzhong Li (Age 53)
VP & Exec. Director
Comp: $831.43k

Dr. Shunjiang Yu
Chief Medical Officer

Ms. Shui Bing Leung A.C.S. (Age 46)
Joint Company Sec.

Mr. Tao Zhong (Age 51)
VP, Board Sec. & Joint Company Sec.

Jinqi Yu
Gen. Mang.

Ying Ke
Director & Gen. Mang. of R&D Management Center

Linqiong Dong
Securities Affairs Representative

Key Competitors

View All Competitors

SHPMF Stock - Frequently Asked Questions

Should I buy or sell Shanghai Pharmaceuticals stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Shanghai Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SHPMF shares.
View SHPMF analyst ratings or view top-rated stocks.
How have SHPMF shares performed in 2023?: Shanghai Pharmaceuticals' stock was trading at $1.62 at the beginning of 2023. Since then, SHPMF stock has increased by 21.0% and is now trading at $1.96.
View the best growth stocks for 2023 here.
Are investors shorting Shanghai Pharmaceuticals?: Shanghai Pharmaceuticals saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 96,000 shares, a decrease of 13.9% from the April 30th total of 111,500 shares. Based on an average daily volume of 800 shares, the short-interest ratio is currently 120.0 days.
View Shanghai Pharmaceuticals' Short Interest.
Is Shanghai Pharmaceuticals a good dividend stock?: Shanghai Pharmaceuticals (OTCMKTS:SHPMF) pays an annual dividend of $0.26 per share and currently has a dividend yield of 2.01%. The dividend payout ratio is 28.26%. This payout ratio is at a healthy, sustainable level, below 75%.

What is Shanghai Pharmaceuticals' stock symbol?: Shanghai Pharmaceuticals trades on the OTCMKTS under the ticker symbol "SHPMF."
How do I buy shares of Shanghai Pharmaceuticals?: Shares of SHPMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Shanghai Pharmaceuticals' stock price today?: One share of SHPMF stock can currently be purchased for approximately $1.96.
How many employees does Shanghai Pharmaceuticals have?: The company employs 48,136 workers across the globe.

This page (OTCMKTS:SHPMF) was last updated on 5/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial